Literature DB >> 3860815

Metabolism of retinoic acid and retinol during differentiation of F9 embryonal carcinoma cells.

J B Williams, J L Napoli.   

Abstract

Retinol and retinoic acid dose-response curves were obtained for promotion of the differentiation of F9 murine embryonal carcinoma cells with an enzyme-linked immunoadsorbent assay for laminin, a product of differentiated F9 cells. Retinoic acid produced a half-maximum response at 1.3 nM and a maximum response at about 30 nM; retinol was 1/175th as potent. Maximum differentiation required 48 hr of continuous exposure to retinoic acid, whereas retinol required 72 hr of exposure. The half-time of retinoic acid conversion into polar metabolites was 3.5 hr; metabolism was accelerated by pretreating F9 cells with retinoic acid. An inhibitor of oxidative metabolism, ketoconazole, decreased the rate of retinoic acid metabolism and decreased the concentration of retinoic acid required to produce a half-maximum response. Unchanged retinoic acid was the sole compound isolated from nuclei of F9 cells incubated with retinoic acid. Retinol had a half-life approximately 5-fold longer than retinoic acid, attained greater cell concentrations, and was converted into retinoic acid by F9 cells. These data indicate that retinoic acid itself directs the differentiation of F9 cells and may mediate differentiation induced by retinol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860815      PMCID: PMC390445          DOI: 10.1073/pnas.82.14.4658

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

2.  Studies on the effect of retinoids on the differentiation of teratocarcinoma stem cells in vitro and in vivo.

Authors:  S Strickland; M J Sawey
Journal:  Dev Biol       Date:  1980-07       Impact factor: 3.582

3.  Effect of retinoic acid treatment of F9 embryonal carcinoma cells on the activity and distribution of cyclic AMP-dependent protein kinase.

Authors:  A Plet; D Evain; W B Anderson
Journal:  J Biol Chem       Date:  1982-01-25       Impact factor: 5.157

4.  Compartmentalization of polyamines in mammalian cells.

Authors:  M Mach; P Ebert; R Popp; A Ogilvie
Journal:  Biochem Biophys Res Commun       Date:  1982-02-26       Impact factor: 3.575

5.  Retinoic acid-induced differentiation of F9 embryonal carcinoma cells.

Authors:  S Linder; U Krondahl; R Sennerstam; N R Ringertz
Journal:  Exp Cell Res       Date:  1981-04       Impact factor: 3.905

6.  Induction of differentiation of embryonal carcinoma cells by retinol: possible mechanisms.

Authors:  A M Jetten; L M De Luca
Journal:  Biochem Biophys Res Commun       Date:  1983-07-29       Impact factor: 3.575

Review 7.  Teratocarcinomas and mammalian embryogenesis.

Authors:  G R Martin
Journal:  Science       Date:  1980-08-15       Impact factor: 47.728

8.  Effects of phenobarbital, 3-methylcholanthrene, and retinoid pretreatment on disposition of orally administered retinoids in mice.

Authors:  J R Kalin; M J Wells; D L Hill
Journal:  Drug Metab Dispos       Date:  1984 Jan-Feb       Impact factor: 3.922

9.  Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.

Authors:  J J Sheets; J I Mason
Journal:  Drug Metab Dispos       Date:  1984 Sep-Oct       Impact factor: 3.922

10.  Metabolism of 5,6-epoxyretinoic acid in vivo: isolation of a major intestinal metabolite.

Authors:  J L Napoli; H Khalil; A M McCormick
Journal:  Biochemistry       Date:  1982-04-13       Impact factor: 3.162

View more
  22 in total

1.  Molecular cloning and analysis of functional cDNA and genomic clones encoding bovine cellular retinoic acid-binding protein.

Authors:  H E Shubeita; J F Sambrook; A M McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 2.  Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases.

Authors:  Joseph L Napoli
Journal:  Pharmacol Ther       Date:  2017-01-27       Impact factor: 12.310

Review 3.  Physiological insights into all-trans-retinoic acid biosynthesis.

Authors:  Joseph L Napoli
Journal:  Biochim Biophys Acta       Date:  2011-05-19

4.  A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell.

Authors:  M A Pratt; J Kralova; M W McBurney
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

Review 5.  Functions of Intracellular Retinoid Binding-Proteins.

Authors:  Joseph L Napoli
Journal:  Subcell Biochem       Date:  2016

6.  The proximal pathway of metabolism of the chlorinated signal molecule differentiation-inducing factor-1 (DIF-1) in the cellular slime mould Dictyostelium.

Authors:  P Morandini; J Offer; D Traynor; O Nayler; D Neuhaus; G W Taylor; R R Kay
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

7.  4-Oxoretinol, a new natural ligand and transactivator of the retinoic acid receptors.

Authors:  C C Achkar; F Derguini; B Blumberg; A Langston; A A Levin; J Speck; R M Evans; J Bolado; K Nakanishi; J Buck; L J Gudas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

8.  An early effect of retinoic acid: cloning of an mRNA (Era-1) exhibiting rapid and protein synthesis-independent induction during teratocarcinoma stem cell differentiation.

Authors:  G J LaRosa; L J Gudas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

9.  Terminal-group oxidation of retinol by mouse epidermis. Inhibition in vitro and in vivo.

Authors:  M J Connor; M H Smit
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

10.  Covalent modification of proteins by ligands of steroid hormone receptors.

Authors:  N Takahashi; T R Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.